Background Chronic viral hepatitis (CVH) is a leading contributor to the UK liver disease epidemic, with global migration from high-prevalence areas (e.g. South Asia-SA). Despite international guidance for testing high-risk groups in line with elimination targets, there is no consensus on how to achieve this. Objectives (i) Feasibility of recruiting SA migrants to view an educational film on CVH (ii) Effectiveness of the film in promoting testing, knowledge of CVH (iii) Methodological issues relevant to scale-up to randomized trial. Methods We recruited SA migrants to view the film (intervention) in community venues (primary care, religious, community), offering dried-blood spot CVH testing immediately afterwards. Pre/post-film que...
Effective strategies are needed to provide screening and treatment for hepatitis B and C to immigran...
© 2015 Owiti et al.; licensee BioMed Central. This is an Open Access article distributed under the t...
MD (Res)Worldwide there are 350 million people with chronic hepatitis B infection and globally it ca...
BACKGROUND:Chronic viral hepatitis (CVH) is a leading contributor to the UK liver disease epidemic, ...
BackgroundChronic viral hepatitis (CVH) is a leading contributor to the UK liver disease epidemic, w...
IntroductionCVH is a leading contributor to the UK’s liver disease epidemic, but is often undiagnose...
In Scotland, an estimated 1% of the population is infected with hepatitis C virus (HCV). There is et...
Viral hepatitis is a significant global health concern, particularly within low-middle income countr...
Viral hepatitis is a significant global health concern, particularly within low-middle income countr...
A dissertation submitted in part fulfilment for the award of degree of Masters in Public HealthMigra...
Background: Viral hepatitis B and C are global health problems and major risk factors for liver cir...
BACKGROUND: The prevalence of viral hepatitis (hepatitis B virus and hepatitis C virus) in migrants ...
Background: Effective strategies are needed to provide screening and treatment for hepatitis B and C...
Background The prevalence of viral hepatitis (hepatitis B virus and hepatitis C virus) in migrants i...
MD Res.Chronic viral hepatitis, caused by Hepatitis B (HBV) or Hepatitis C (HCV) infection is a glob...
Effective strategies are needed to provide screening and treatment for hepatitis B and C to immigran...
© 2015 Owiti et al.; licensee BioMed Central. This is an Open Access article distributed under the t...
MD (Res)Worldwide there are 350 million people with chronic hepatitis B infection and globally it ca...
BACKGROUND:Chronic viral hepatitis (CVH) is a leading contributor to the UK liver disease epidemic, ...
BackgroundChronic viral hepatitis (CVH) is a leading contributor to the UK liver disease epidemic, w...
IntroductionCVH is a leading contributor to the UK’s liver disease epidemic, but is often undiagnose...
In Scotland, an estimated 1% of the population is infected with hepatitis C virus (HCV). There is et...
Viral hepatitis is a significant global health concern, particularly within low-middle income countr...
Viral hepatitis is a significant global health concern, particularly within low-middle income countr...
A dissertation submitted in part fulfilment for the award of degree of Masters in Public HealthMigra...
Background: Viral hepatitis B and C are global health problems and major risk factors for liver cir...
BACKGROUND: The prevalence of viral hepatitis (hepatitis B virus and hepatitis C virus) in migrants ...
Background: Effective strategies are needed to provide screening and treatment for hepatitis B and C...
Background The prevalence of viral hepatitis (hepatitis B virus and hepatitis C virus) in migrants i...
MD Res.Chronic viral hepatitis, caused by Hepatitis B (HBV) or Hepatitis C (HCV) infection is a glob...
Effective strategies are needed to provide screening and treatment for hepatitis B and C to immigran...
© 2015 Owiti et al.; licensee BioMed Central. This is an Open Access article distributed under the t...
MD (Res)Worldwide there are 350 million people with chronic hepatitis B infection and globally it ca...